EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LTF promotes central nervous system leukemia progression via neutrophil serine proteases

Yiran Zhang, Huasong Yu, Zhongxiang Jiao, Ming Yang, Wenshan Zhang, Chaoqun Wang, Hexiao Zhang, Wei Wang, Minghe Zhang, Xiaoyue Li, Lin Song, Bo Jiang und 3 weitere

Frontiers in Pharmacology · 01.07.2026 · 17

DOI: 10.3389/fphar.2026.1813396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.07.2026. Verfasst von Yiran Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute …. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Central nervous system (CNS) infiltration is a severe complication of acute myeloid leukemia (AML), often leading to relapse and poor prognosis. The underlying mechanisms remain poorly understood, limiting the development of effective targeted therapies. Conventional chemotherapy agents capable of crossing the blood-brain barrier (BBB) carry significant toxicity and fail to eliminate leukemia stem cells.

Methods

Using multiple clinical cohorts, we established prognostic prediction model for AML. Using knockdown and overexpression experiments in a mouse leukemia CNS infiltration model, the role of risk factor gene in CNS infiltration was evaluated, along with the attenuating effect of its downstream proteins drug inhibition on leukemia CNS infiltration.

Results

We identify Lactoferrin (LTF) as a risk factor associated with poor AML prognosis using a machine learning–based prognostic model. Through LTF knockdown and overexpression in a mouse leukemia model, we demonstrate its pivotal role in CNS invasion. Mechanistically, neutrophil serine proteases (NSPs) act as downstream effectors of LTF, and pharmacological inhibition with Brensocatib effectively blocks AML cell entry into the brain.

Discussion

Our findings establish LTF as a mediator of CNS infiltration in AML and highlight NSP inhibition as a promising therapeutic strategy.

Schlagwörter

Stichwörter der Autor:innen

acute myeloid leukemiabrensocatibcentral nervous system leukemialactoferrinneutrophil serine proteases

Autor:innen und Institutionen

  • State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical…
  • Tianjin Institutes of Health Science, Tianjin, China.
  • Department of Pharmacy, Children's Hospital of Soochow University, Suzhou, Jiangsu, China.

Zitieren

APA

Zhang, Y., Yu, H., Jiao, Z., Yang, M., Zhang, W., Wang, C., Zhang, H., Wang, W., Zhang, M., Li, X., Song, L., Jiang, B., Qi, J., Li, Y., & Gao, Y. (2026). LTF promotes central nervous system leukemia progression via neutrophil serine proteases. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1813396

Vancouver

Zhang Y, Yu H, Jiao Z, Yang M, Zhang W, Wang C, et al. LTF promotes central nervous system leukemia progression via neutrophil serine proteases. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1813396

BibTeX
@article{Zhang2026,
  author = {Zhang, Yiran and Yu, Huasong and Jiao, Zhongxiang and Yang, Ming and Zhang, Wenshan and Wang, Chaoqun and Zhang, Hexiao and Wang, Wei and Zhang, Minghe and Li, Xiaoyue and Song, Lin and Jiang, Bo and Qi, Junyuan and Li, Yinghui and Gao, Yingdai},
  title = {LTF promotes central nervous system leukemia progression via neutrophil serine proteases},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1813396}
}
Kostenlos starten →